Evaluation of Sch 29,482 in the eradication of Neisseria meningitidis from nasopharyngeal carriers.

Fifty-eight chronic carriers of Neisseria meningitidis were given 250 mg of Sch 29,482 or placebo orally every 6 h for 4 days. Although 22 of 29 subjects taking Sch 29,482 became culture negative while taking the drug, only five were culture negative 2 weeks posttherapy. There were no significant ad...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Εκδόθηκε σε:	Antimicrob Agents Chemother
Κύριοι συγγραφείς:	Pugsley, M P, Dworzack, D L, Sanders, C C, Sanders, W E
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	American Society for Microbiology (ASM) 1984
Θέματα:	Research Article
Διαθέσιμο Online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185560/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6732217/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.25.4.494
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!